oleanolic acid has been researched along with endothelin-1 in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Haque, MS; Kitazawa, Y; Nakai, Y; Okada, K; Sugiyama, K; Taniguchi, T | 1 |
| Masuda, K; Oshika, T; Shoji, N | 1 |
| Fujimoto, M; Kita, T; Kubo, K; Nakashima, T; Sato, S; Yonetani, Y | 1 |
| Amano, S; Masuda, K; Oshika, T; Shoji, N | 1 |
| Kita, T; Kubo, K; Momochi, C; Nakashima, T; Narushima, I; Shimada, K; Yonetani, Y; Yoshikawa, I | 1 |
| Hayasaki-Kajiwara, Y; Iwasaki, T; Nakajima, M; Naya, N; Shimamura, T | 1 |
| Inagaki, K; Kihara, Y; Sasayama, S; Takeuchi, Y; Yoneda, T | 1 |
| Fujimoto, M; Matsuo, Y; Ninomiya, M | 1 |
| Albala, B; Francis-Lang, A; Laurijssens, BE; Lunnon, MW; Maltby, K; Mistry, P; Nagafuji, T; Palmer, JE; Wallace, SM; Wilkinson, IB | 1 |
| Abramowitz, MK; Bauer, C; Hostetter, TH; Melamed, ML; Turner, JM | 1 |
| Cherng, JY; Shih, MF | 1 |
| Akcilar, R; Aras, B; Bayat, Z; Kocak, C; Kocak, FE; Metineren, MH; Simsek, H; Yucel, M | 1 |
| Campagna, R; Chlopicki, S; Grosicki, M; Jamrozik, M; Kaczara, P; Stojak, M; Szczesny-Malysiak, E | 1 |
1 review(s) available for oleanolic acid and endothelin-1
| Article | Year |
|---|---|
Treatment of chronic kidney disease.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Diabetes Mellitus, Type 2; Disease Progression; Endothelin-1; Humans; Hypertension; Kidney Failure, Chronic; Oleanolic Acid; Pyridones; Renal Insufficiency, Chronic; Renin-Angiotensin System | 2012 |
12 other study(ies) available for oleanolic acid and endothelin-1
| Article | Year |
|---|---|
The effects of ETB receptor-selective agonist on IOP and blood-aqueous barrier in rabbit eyes: role of cyclooxygenase products.
Topics: Animals; Aqueous Humor; Blood-Aqueous Barrier; Caffeic Acids; Cyclooxygenase Inhibitors; Dinoprostone; Endothelin-1; Eye Proteins; Female; Indomethacin; Intraocular Pressure; Male; Oleanolic Acid; Prostaglandin-Endoperoxide Synthases; Rabbits; Receptors, Endothelin; Vasoconstrictor Agents; Viper Venoms | 1995 |
[Anterior chamber inflammation after the injection of endothelin-1 into the vitreous and the effect of ETA receptor antagonist].
Topics: Animals; Anterior Chamber; Aqueous Humor; Caffeic Acids; Dinoprostone; Endothelin Receptor Antagonists; Endothelin-1; Female; Inflammation; Leukotriene B4; Male; Oleanolic Acid; Rabbits; Receptor, Endothelin A; Receptors, Endothelin; Vitreous Body | 1997 |
Effects of an endothelin ET(A)-receptor antagonist, S-0139, on cerebral vasospasm and behavioral changes in dogs intracisternally administered endothelin-1.
Topics: Animals; Basilar Artery; Behavior, Animal; Cerebrovascular Circulation; Dogs; Drug Interactions; Endothelin Receptor Antagonists; Endothelin-1; Female; Ischemic Attack, Transient; Male; Oleanolic Acid; Receptor, Endothelin A; Vasoconstriction | 1998 |
Effects of endothelin receptor antagonists on anterior chamber inflammation induced by intravitreal injection of endothelin-1.
Topics: Animals; Caffeic Acids; Dinoprostone; Endothelin Receptor Antagonists; Endothelin-1; Eye Proteins; Female; Leukotriene B4; Male; Oleanolic Acid; Oligopeptides; Piperidines; Rabbits; Receptors, Endothelin; Uveitis, Anterior | 1999 |
Contribution of endothelin-1 to disruption of blood-brain barrier permeability in dogs.
Topics: Analysis of Variance; Animals; Blood; Blood-Brain Barrier; Caffeic Acids; Cell Membrane Permeability; Cisterna Magna; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Female; Fluorescein; Injections, Intraventricular; Male; Oleanolic Acid; Receptor, Endothelin A; Subarachnoid Hemorrhage | 1999 |
Endothelin receptor subtype antagonist activity of S-0139 in various isolated rabbit and canine arteries.
Topics: Animals; Arteries; Caffeic Acids; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-3; Endothelium, Vascular; In Vitro Techniques; Isometric Contraction; Male; Muscle, Smooth, Vascular; Oleanolic Acid; Rabbits; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Vasoconstrictor Agents; Viper Venoms | 2000 |
Endothelin-1 has a unique oxygen-saving effect by increasing contractile efficiency in the isolated rat heart.
Topics: Amiloride; Animals; Antihypertensive Agents; Caffeic Acids; Cardiotonic Agents; Drug Interactions; Endothelin-1; Heart; In Vitro Techniques; Male; Myocardial Contraction; Myocardial Ischemia; Oleanolic Acid; Oligopeptides; Oxygen; Perfusion; Piperidines; Rats; Rats, Sprague-Dawley | 2001 |
Protective effect of endothelin type A receptor antagonist on brain edema and injury after transient middle cerebral artery occlusion in rats.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Chemistry; Brain Edema; Caffeic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Male; Neuroprotective Agents; Oleanolic Acid; Peroxidase; Rats; Rats, Wistar; Receptor, Endothelin A; Reperfusion Injury; Survival Rate; Time Factors; Water | 2001 |
Prolonged pharmacodynamic effects of S-0139, an intravenously administered endothelin A (ET) antagonist, in the human forearm blood flow model.
Topics: Adolescent; Adult; Blood Pressure; Caffeic Acids; Double-Blind Method; Endothelin A Receptor Antagonists; Endothelin-1; Forearm; Humans; Infusions, Intravenous; Male; Middle Aged; Oleanolic Acid; Plethysmography; Single-Blind Method; Vasoconstriction; Vasoconstrictor Agents; Young Adult | 2010 |
Reduction of adhesion molecule production and alteration of eNOS and endothelin-1 mRNA expression in endothelium by Euphorbia hirta L. through its beneficial β-amyrin molecule.
Topics: Cell Line; Endothelial Cells; Endothelin-1; Euphorbia; Gene Expression Regulation; Humans; Intercellular Adhesion Molecule-1; Nitric Oxide Synthase Type III; Oleanolic Acid; RNA, Messenger; Vascular Cell Adhesion Molecule-1 | 2014 |
Effects of captopril, telmisartan and bardoxolone methyl (CDDO-Me) in ischemia-reperfusion-induced acute kidney injury in rats: an experimental comparative study.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Animals; Antioxidants; Apoptosis; Arginine; Benzimidazoles; Benzoates; Captopril; Creatine; Endothelin-1; Gene Expression Regulation; Glutathione Peroxidase; Ischemia; Kidney; Lipocalin-2; Lipocalins; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oleanolic Acid; Proto-Oncogene Proteins; Rats; Rats, Wistar; Reperfusion Injury; Sulfhydryl Compounds; Superoxide Dismutase; Telmisartan; Urea | 2016 |
Bardoxolone Methyl Displays Detrimental Effects on Endothelial Bioenergetics, Suppresses Endothelial ET-1 Release, and Increases Endothelial Permeability in Human Microvascular Endothelium.
Topics: Cell Line; Cell Survival; Dimethyl Fumarate; Down-Regulation; Endothelial Cells; Endothelin-1; Gene Expression; Humans; Isothiocyanates; Membrane Potential, Mitochondrial; Microvessels; Mitochondria; NF-E2-Related Factor 2; Oleanolic Acid; Permeability; Reactive Oxygen Species; Sulfoxides | 2020 |